Uncategorized - July 21, 2020
HAIFA, Israel, July 21, 2020 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a […]
Read More
Uncategorized - July 21, 2020
LEIDEN, Netherlands & CAMBRIDGE, Mass., July 21, 2020 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives […]
Read More
Uncategorized - July 21, 2020
ROCKVILLE, Md., July 21, 2020 (GLOBE NEWSWIRE) — Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader […]
Read More
Uncategorized - July 21, 2020
THE WOODLANDS, Texas, July 21, 2020 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced topline data from four […]
Read More
Uncategorized - July 21, 2020
EWING, N.J., July 21, 2020 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares”) (“the Company”), a pharmaceutical technology company, […]
Read More
Uncategorized - July 21, 2020
TALLAHASSEE, Fla., July 21, 2020 (GLOBE NEWSWIRE) — Capital City Bank Group, Inc. (NASDAQ: CCBG) today reported net income of […]
Read More
Uncategorized - July 21, 2020
BIRKIRKARA, Malta, July 21, 2020 (GLOBE NEWSWIRE) — Esports Entertainment Group, Inc. (NasdaqCM: GMBL, GMBLW) (or the “Company”), a licensed […]
Read More
Uncategorized - July 21, 2020
TEL-AVIV, Israel and RALEIGH, N.C., July 21, 2020 (GLOBE NEWSWIRE) — RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), […]
Read More
Uncategorized - July 21, 2020
Immuron’s IMM-124E used to manufacture Travelan® and Protectyn® demonstrates antiviral activity against the COVID-19 virus in laboratory studiesImmuron’s technology platform […]
Read More
Uncategorized - July 21, 2020
Achieved GAAP EPS of $0.12; non-GAAP EPS of $0.10, Performing Well in Challenging COVID-19 Pandemic EnvironmentOperating Margin Increased 30 Basis Points […]
Read More